BRIEF-Collegium Announces Authorized Agreement With Hikma Pharmaceuticals USA For Nucynta

Dow Jones Industrial Average +0.59%
Collegium Pharmaceutical, Inc. -0.03%
S&P 500 index -1.39%
NASDAQ -2.77%

Collegium Pharmaceutical, Inc.

COLL

31.94

-0.03%

Dow Jones Industrial Average

DJI

41198.08

+0.59%

S&P 500 index

SPX

5588.27

-1.39%

NASDAQ

IXIC

17996.92

-2.77%

- Collegium Pharmaceutical Inc COLL.O:

  • COLLEGIUM ANNOUNCES AUTHORIZED GENERIC AGREEMENT WITH HIKMA PHARMACEUTICALS USA INC. FOR NUCYNTA® AND NUCYNTA® ER

  • COLLEGIUM: HIKMA WILL HAVE EXCLUSIVE RIGHT TO SELL AUTHORIZED GENERIC VERSIONS OF NUCYNTA & NUCYNTA ER IN U.S.

Source text for Eikon: ID:nGNX7yGX8W

Further company coverage: COLL.O


((Reuters.Briefs@thomsonreuters.com;))

Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via